Orelabrutinib Maintenance Therapy After ASCT in Primary Central Nervous System Lymphoma
Clinical trial NCT05334238 · UNKNOWN
Trial details
- NCT number
- NCT05334238
- Sponsor
- Ruijin Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2024-05-30
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.